Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.17−0.02 (-0.63%)
Close on Nov 18, 2026Market cap $1.17BP/E 15.8Yield –
Cronos net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cronos's net income for the twelve months ending Jun 30, 2026 was $69.98M, up 278.5% year over year. For fiscal 2025 it was -$9.45M, down 123.0% from the year before. The highest annual figure on record is $1.17B in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.45M | -123.0% |
| FY2024 | Dec 31, 2024 | $41.08M | – |
| FY2023 | Dec 31, 2023 | -$73.96M | – |
| FY2022 | Dec 31, 2022 | -$168.73M | – |
| FY2021 | Dec 31, 2021 | -$396.11M | – |
| FY2020 | Dec 31, 2020 | -$73.14M | -106.3% |
| FY2019 | Dec 31, 2019 | $1.17B | – |
| FY2018 | Dec 31, 2018 | -$21.64M | – |
| FY2017 | Dec 31, 2017 | -$1.48M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $32.09M | – |
| Q1 FY2026 | Mar 31, 2026 | $13.75M | +124.6% |
| Q4 FY2025 | Dec 31, 2025 | -$1.82M | -104.2% |
| Q3 FY2025 | Sep 30, 2025 | $25.96M | +210.9% |
| Q2 FY2025 | Jun 30, 2025 | -$39.71M | – |
| Q1 FY2025 | Mar 31, 2025 | $6.12M | – |
| Q4 FY2024 | Dec 31, 2024 | $43.73M | – |
| Q3 FY2024 | Sep 30, 2024 | $8.35M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.76M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$44.79M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$8.36M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.17M | – |
| Q4 FY2022 | Dec 31, 2022 | -$78.88M | – |
| Q3 FY2022 | Sep 30, 2022 | -$36.99M | -147.5% |
| Q2 FY2022 | Jun 30, 2022 | -$20.22M | – |
| Q1 FY2022 | Mar 31, 2022 | -$32.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$133.64M | – |
| Q3 FY2021 | Sep 30, 2021 | $77.92M | +12.9% |
| Q2 FY2021 | Jun 30, 2021 | -$179.07M | – |
| Q1 FY2021 | Mar 31, 2021 | -$161.31M | -312.1% |
| Q4 FY2020 | Dec 31, 2020 | -$111.23M | -279.4% |
| Q3 FY2020 | Sep 30, 2020 | $69.03M | -88.6% |
| Q2 FY2020 | Jun 30, 2020 | -$106.98M | -157.5% |
| Q1 FY2020 | Mar 31, 2020 | $76.04M | -75.8% |
| Q4 FY2019 | Dec 31, 2019 | $62.01M | – |
| Q3 FY2019 | Sep 30, 2019 | $604.41M | – |
| Q2 FY2019 | Jun 30, 2019 | $186.00M | – |
| Q1 FY2019 | Mar 31, 2019 | $314.09M | – |
See a number that looks wrong?